nDatalyze Corp. anticipates YMI ChatGPT testing
(TheNewswire)
 | |||||||||
 |  |  |  | ||||||
Calgary, Alberta – TheNewswire - January 25, 2023 - nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) is pleased to report that OpenAI’s ChatGPT chatbot will be made available as a part of Microsoft's Azure OpenAI service*. The service on Azure lets Microsoft’s enterprise customers apply OpenAI’s artificial intelligence models to their business applications.
James Durward, NDAT's President states "Our advanced predictive pre-diagnostic mental condition tool, YMI, was developed within Microsoft's AZURE ecosystem and incorporates AZURE's machine-learning offering within YMI's overall proprietary algorithm that includes our application-specific Reference Database. The Reference Database is critical as it addresses multiple problematical issues within the AI field - data availability, quality, format, consistency and applicability. AI applications can be highly advanced but they still largely depend on data quality and availability. I am very excited about the promise of ChatGPT and also to see that ChatGPT will be offered through AZURE as an application programming interface ("API"). As YMI is already hosted within AZURE the API should expedite the testing of ChatGPT within the YMI application."
*https://techinformed.com/openais-chatgpt-will-be-available-as-an-api-soon/
About ChatGPT
According to Wikipedia**, ChatGPT (Chat Generative Pre-trained Transformer) is a chatbot launched by OpenAI in November 2022. It is built on top of OpenAI's GPT-3 family of large language models, and is fine-tuned (an approach to transfer learning) with both supervised and reinforcement learning techniques.
ChatGPT was launched as a prototype on November 30, 2022, and quickly garnered attention for its detailed responses and articulate answers across many domains of knowledge. Following the release of ChatGPT, OpenAI was valued at $29 billion.
** https://en.wikipedia.org/wiki/ChatGPT
About YMI
YMI uses a holistic, evidence-based, objective data from whole life experiences to predict why you are who you are, and applies this knowledge towards a fuller understanding of how to improve your mental wellbeing. After registering at ymihealth (https://ymihealth.ca) users are given access to a private, in-depth survey that applies artificial intelligence using a person's genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle. Upon completion of the survey, YMI generates a personalized graphic report predicting a person's predisposition for seven mental conditions including anxiety, depression, post-traumatic stress disorder, obsessive compulsive disorder, alcoholism, and personality disorders both current and forward in time. The downloadable report may be used for reference as the user considers changes to their lifestyle that may help improve their mental wellbeing and mental health journey. The service also helps connect users with therapists who are prepared to help with next steps, providing further clarity and treatment as required.
About nDatalyze Corp.:
nDatalyze Corp. generates technology-based, health-related solutions. It's machine-learning processed, online consumer mental health application known as "YMI" is based on the Corporation's proprietary Reference Database consisting of >1200 biometric records complete with associated electroencephalogram ("EEG") data. YMI has only recently begun its initial staged launch and accordingly the Corporation cannot accurately predict if or when this application will become a profit generator.
FOR FURTHER INFORMATION, PLEASE CONTACT:
nDatalyze Corp.
James Durward, President and CEO
Telephone: (403) 689-3901
Email: [email protected] Website: www.ndatalyze.com
Investor Relations
RBMG - RB Milestone Group LLC
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Copyright (c) 2023 TheNewswire - All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
